Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (321-330 of 587) with videos related to

Pageof 59
Sort By:
Neuroscience Letters|December 29, 1995
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsD Blum-Degen, T Müller, W Kuhn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Macaque animal model for HIV-induced neurological diseaseS Sopper, E Koutsilieri, C Scheller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 7, 2006
Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometryA Dzierzega-Lecznar, S Kurkiewicz, K Stepien, et al.
Brain Research|October 9, 1989
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortexJ Kornhuber, C Konradi, F Mack-Burkhardt, et al.
Molecular Pathology : MP|November 29, 2001
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviourL Zecca, D Tampellini, M Gerlach, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
The serotonin transporter in Alzheimer's and Parkinson's diseaseR Mössner, A Schmitt, Y Syagailo, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|August 4, 1999
Pro- and antioxidative properties of cortical tissue preparations from human brain exhibiting NMDA-receptor characteristicsM Elstner, A Denke, W Gsell, et al.
Brain Research|November 25, 1996
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal levelA Kupsch, J Sautter, J Schwarz, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
Intranigral injected iron progressively reduces striatal dopamine metabolismW Wesemann, S Blaschke, M Solbach, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 13, 2006
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexityF Tribl, K Marcus, G Bringmann, et al.
Pageof 59

Showing results (321-330 of 587) with videos related to

Sort By:
Pageof 59
Neuroscience Letters|December 29, 1995
Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patientsD Blum-Degen, T Müller, W Kuhn, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2002
Macaque animal model for HIV-induced neurological diseaseS Sopper, E Koutsilieri, C Scheller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 7, 2006
Structural investigations of neuromelanin by pyrolysis-gas chromatography/mass spectrometryA Dzierzega-Lecznar, S Kurkiewicz, K Stepien, et al.
Brain Research|October 9, 1989
Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortexJ Kornhuber, C Konradi, F Mack-Burkhardt, et al.
Molecular Pathology : MP|November 29, 2001
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviourL Zecca, D Tampellini, M Gerlach, et al.
Journal of Neural Transmission. Supplementum|February 24, 2001
The serotonin transporter in Alzheimer's and Parkinson's diseaseR Mössner, A Schmitt, Y Syagailo, et al.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences|August 4, 1999
Pro- and antioxidative properties of cortical tissue preparations from human brain exhibiting NMDA-receptor characteristicsM Elstner, A Denke, W Gsell, et al.
Brain Research|November 25, 1996
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal levelA Kupsch, J Sautter, J Schwarz, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1994
Intranigral injected iron progressively reduces striatal dopamine metabolismW Wesemann, S Blaschke, M Solbach, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 13, 2006
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexityF Tribl, K Marcus, G Bringmann, et al.
Pageof 59